These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12940236)

  • 1. A simplified and comprehensive computational model to study the behavior of T cell populations in the thymus during normal maturation and in infection with mouse moloney leukemiavirus.
    Wang G; Krueger GR; Buja LM
    In Vivo; 2003; 17(3):225-8. PubMed ID: 12940236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 3. A continuous model studying T cell differentiation and lymphomagenesis and its distinction with discrete models.
    Wang G; Krueger GR; Buja LM
    Anticancer Res; 2004; 24(3a):1813-6. PubMed ID: 15274360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1981 Apr; 126(4):1478-84. PubMed ID: 6970777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody formation, latency and leukemia: infection with Moloney virus.
    Cremer NE; Taylor DO; Hagens SJ
    J Immunol; 1966 Mar; 96(3):495-508. PubMed ID: 5932581
    [No Abstract]   [Full Text] [Related]  

  • 7. TCM-1: a nonlinear dynamical computational model to simulate cellular changes in the T cell system; conceptional design and validation.
    Krueger GR; Brandt ME; Wang G; Buja LM
    Anticancer Res; 2003; 23(1A):123-35. PubMed ID: 12680203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.
    Carrio R; Lopez DM
    Int J Mol Med; 2009 Jan; 23(1):89-98. PubMed ID: 19082511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Toxoplasma on manifestations of Moloney virus infections.
    McLeod R; Estes RG; Cohen H
    Trans R Soc Trop Med Hyg; 1985; 79(6):781-7. PubMed ID: 2938310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
    Pepersack L; Lee JC; McEwan R; Ihle JN
    J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of different components of the thymic stroma on the onset of AKR leukaemia.
    Fournier M; Potworowski EF
    Clin Exp Immunol; 1979 Sep; 37(3):512-6. PubMed ID: 509783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression.
    Lee JC; Enjuanes L; Cicurel L; Ihle JN
    J Immunol; 1981 Jul; 127(1):78-83. PubMed ID: 6972414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity in vitro of preleukaemic lymphoid cells on syngeneic monolayers of embryo or thymus cells.
    Wahren B; Metcalf D
    Clin Exp Immunol; 1970 Sep; 7(3):373-86. PubMed ID: 5477935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome conditions of hypodiploid moloney virus-induced mouse leukemia, its transplantability and inductivity.
    Ida N; Ohba Y; Fukuhara A; Kohno M
    J Natl Cancer Inst; 1968 Jan; 40(1):97-105. PubMed ID: 5635019
    [No Abstract]   [Full Text] [Related]  

  • 15. Uropod-bearing lymphocytes (hand mirror cells) in a virus-induced murine lymphoma.
    Schumacher HR; Stass SA; Creegan WJ; Weislow OS
    J Natl Cancer Inst; 1979 Oct; 63(4):1051-5. PubMed ID: 314520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.
    Delebecque F; Combredet C; Gabet AS; Wattel E; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):255-63. PubMed ID: 15609236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance.
    Chieco-Bianchi L; Collavo D; Zanovell P; De Rossi A; Davies AJ
    Nature; 1980 Jun; 285(5767):667-8. PubMed ID: 6248790
    [No Abstract]   [Full Text] [Related]  

  • 18. Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data.
    Ribeiro RM; Perelson AS
    Immunol Rev; 2007 Apr; 216():21-34. PubMed ID: 17367332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex regulation of CCR9 at multiple discrete stages of T cell development.
    Wurbel MA; Malissen B; Campbell JJ
    Eur J Immunol; 2006 Jan; 36(1):73-81. PubMed ID: 16342233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal T cell development in the absence of thymic insulin expression.
    Carlsén M; Cilio CM
    Ann N Y Acad Sci; 2006 Oct; 1079():205-12. PubMed ID: 17130556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.